
Patient perspectives fuelling translational OICR studies
People with lived experience of cancer are bringing crucial insights to studies aimed at making a clinical impact. The early days after Gary Davis’s leukemia diagnosis were all a blur. The retired Ottawa resident learned he had acute promyelocytic leukemia — an aggressive form of acute myeloid leukemia (AML) — in 2017 after a sudden onset of severe symptoms. Almost immediately, he was admitted to the leukemia ward at The








